These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 8661345)

  • 21. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of liver protein changes in mice and hamsters treated with the peroxisome proliferator Wy-14,643.
    Giometti CS; Tollaksen SL; Liang X; Cunningham ML
    Electrophoresis; 1998 Oct; 19(14):2498-505. PubMed ID: 9820974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol potentiates oxygen uptake and toxicity due to menadione bisulfite in perfused rat liver.
    Ganey PE; Takei Y; Kauffman FC; Thurman RG
    Mol Pharmacol; 1990 Dec; 38(6):959-64. PubMed ID: 2250668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of peroxisomes in the swift increase in alcohol metabolism.
    Bradford BU
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S28-30. PubMed ID: 17567460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the liver peroxisomal fatty acyl-CoA beta-oxidation system with the synthesis of bile acids.
    Hayashi H; Fukui K; Yamasaki F
    J Biochem; 1984 Dec; 96(6):1713-9. PubMed ID: 6530393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of peroxisomes by treatment with perfluorooctanoate does not increase rates of H2O2 production in intact liver.
    Handler JA; Seed CB; Bradford BU; Thurman RG
    Toxicol Lett; 1992 Jan; 60(1):61-8. PubMed ID: 1539182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of reducing equivalents from fatty acid oxidation in mixed-function oxidation: studies with 2-bromooctanoate in the perfused rat liver.
    Danis M; Kauffman FC; Evans RK; Thurman RG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):383-8. PubMed ID: 7288627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the hepatocarcinogenic peroxisome proliferator Wy-14,643 in vivo: no increase in ethane exhalation or hepatic conjugated dienes.
    Conway JG; Popp JA
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):229-36. PubMed ID: 8545832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acids supply H2O2 at high rates for the oxidation of ethanol by catalase.
    Handler JA; Thurman RG
    Alcohol Alcohol Suppl; 1987; 1():225-9. PubMed ID: 3426684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
    Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
    Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.
    Richert L; Price S; Chesne C; Maita K; Carmichael N
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):35-43. PubMed ID: 8917673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that catalase is a major pathway of ethanol oxidation in vivo: dose-response studies in deer mice using methanol as a selective substrate.
    Bradford BU; Seed CB; Handler JA; Forman DT; Thurman RG
    Arch Biochem Biophys; 1993 May; 303(1):172-6. PubMed ID: 8489262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalase-dependent ethanol oxidation in perfused rat liver. Requirement for fatty-acid-stimulated H2O2 production by peroxisomes.
    Handler JA; Thurman RG
    Eur J Biochem; 1988 Sep; 176(2):477-84. PubMed ID: 3416882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats.
    Mannaerts GP; Debeer LJ; Thomas J; De Schepper PJ
    J Biol Chem; 1979 Jun; 254(11):4585-95. PubMed ID: 438207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.
    Noland RC; Woodlief TL; Whitfield BR; Manning SM; Evans JR; Dudek RW; Lust RM; Cortright RN
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E986-E1001. PubMed ID: 17638705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine increases hepatic oxygen uptake in the isolated perfused rat liver by inhibiting glycolysis.
    Dewar BJ; Bradford BU; Thurman RG
    J Pharmacol Exp Ther; 2002 Jun; 301(3):930-7. PubMed ID: 12023521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation of epithelial cells stably transfected with H2O2-generating peroxisomal urate oxidase.
    Chu R; Lin Y; Reddy KC; Pan J; Rao MS; Reddy JK; Yeldandi AV
    Cancer Res; 1996 Nov; 56(21):4846-52. PubMed ID: 8895731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased response to peroxisomal proliferators in starved rats.
    Hertz R; Bar-Tana J
    Biochim Biophys Acta; 1987 Jan; 917(1):57-61. PubMed ID: 3790611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
    Eacho PI; Lanier TL; Brodhecker CA
    Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.